Kintara Therapeutics, Inc.
Kintara Therapeutics, Inc. (KTRA) Stock Overview
Explore Kintara Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
12M
P/E Ratio
-0.43
EPS (TTM)
$-11.20
ROE
-2.13%
KTRA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Kintara Therapeutics, Inc. (KTRA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.43 and a market capitalization of 12M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.